Position in ALEC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,549,517
-$1,082,359 QoQ
Shares Held
1,765,929
-18.0% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 140 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $740,535,030 across 80 Biotechnology names. ALEC ranks #31 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in ALEC
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,549,517 | 1,765,929 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,631,876 | 2,154,361 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,390,195 | 2,173,202 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,643,683 | 1,230,974 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,852,034 | 1,322,882 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,640,859 | 1,334,032 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,002,815 | 1,059,691 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,742,421 | 1,017,687 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,897,935 | 858,576 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,555,249 | 922,799 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,338,386 | 794,284 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,041,938 | 778,077 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $3,501,822 | 582,666 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,653,628 | 428,696 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,980,767 | 214,601 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,943,746 | 205,470 | Shares | Sole | 2022-11-15 | |
| 2020-06-30 | $451,651 | 18,480 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||